China Resources Pharmaceutical Group Limited Stock
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
11:08:35 15/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.710 HKD | +1.95% |
|
+9.79% | +5.84% |
| 10-01 | China Resources Pharmaceuticals Needs More Than Distribution Scale to Win |  |
| 09-01 | China Resources Pharma Unit's Bond Program Registration Accepted in China | MT |
| Market Cap | 29.59B 3.77B 3.37B 3.13B 2.85B 5.35B 357B 5.45B 37.58B 14.7B 186B 14.15B 13.85B 596B | P/E 2026 * |
6.04x | P/E 2027 * | 5.67x |
|---|---|---|---|---|---|
| Enterprise Value | 78.83B 10.05B 8.97B 8.33B 7.58B 14.26B 951B 14.52B 100B 39.17B 496B 37.7B 36.9B 1,588B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.21x |
| Free-Float |
29.17% | Yield 2026 * |
4.32% | Yield 2027 * | 4.68% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3320 | Delayed | |
Tradegate
| 640 | Real-time | |
|
Deutsche Boerse AG
| 640 | Delayed | |
|
Börse Stuttgart
| 640 | Delayed | |
|
Boerse Muenchen
| 640 | Real-time |
| 1 day | +1.95% | ||
| 1 week | +9.79% | ||
| Current month | +5.84% | ||
| 1 month | +9.28% | ||
| 3 months | +1.95% | ||
| 6 months | -24.52% | ||
| Current year | +5.84% |
| 1 week | 4.29 |  | 4.72 |
| 1 month | 4.22 | | 4.72 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 26/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 13/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 15/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Fang Jiao
BRD | Director/Board Member | 49 | 14/01/2022 |
Ting Mei Fu
BRD | Director/Board Member | 59 | 01/06/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 20/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/1/20 A | Other | Chief Executive Officer | 200,000 | 0.0032% | ||
| 3/31/20 A | Other | Chief Executive Officer | 100,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.95% | +9.79% | -1.26% | -6.92% | 3.7B | |
| +5.13% | +8.72% | +53.84% | +106.21% | 1,077B | |
| +1.07% | +0.36% | +34.65% | +63.40% | 612B | |
| +2.45% | +5.59% | +27.16% | +95.38% | 501B | |
| +1.60% | +5.26% | +78.18% | +43.91% | 364B | |
| +2.37% | +7.66% | +33.65% | +50.58% | 353B | |
| +2.64% | +6.95% | +21.01% | +44.38% | 278B | |
| +3.24% | +6.78% | +0.43% | +15.73% | 251B | |
| +3.23% | +7.76% | +47.67% | +53.05% | 230B | |
| +3.71% | +8.11% | +34.43% | +100.80% | 190B | |
| Average | +2.68% | +2.54% | +32.98% | +56.65% | 386.02B | |
| Weighted average by Cap. | +3.01% | +1.59% | +40.57% | +73.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 328B 41.78B 37.29B 34.66B 31.52B 59.31B 3,957B 60.38B 416B 163B 2,064B 157B 153B 6,606B | 341B 43.42B 38.76B 36.02B 32.77B 61.65B 4,113B 62.76B 433B 169B 2,146B 163B 160B 6,867B |
| Net income | 4.82B 615M 549M 510M 464M 873M 58.23B 888M 6.13B 2.4B 30.38B 2.31B 2.26B 97.21B | 5.18B 660M 589M 547M 498M 937M 62.5B 954M 6.58B 2.57B 32.61B 2.48B 2.42B 104B |
| Net Debt | 49.24B 6.27B 5.6B 5.21B 4.73B 8.91B 594B 9.07B 62.52B 24.46B 310B 23.55B 23.05B 992B | 42.53B 5.42B 4.84B 4.5B 4.09B 7.69B 513B 7.83B 54.01B 21.13B 268B 20.34B 19.91B 857B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | HK$4.710 | +1.95% | 16,109,099 |
| 14/10/26 | HK$4.620 | +2.67% | 13,392,500 |
| 13/10/26 | HK$4.500 | +2.86% | 7,433,365 |
| 12/10/26 | HK$4.375 | -0.11% | 6,357,148 |
| 09/10/26 | HK$4.380 | +0.92% | 4,783,538 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
